February 2, 2018
Pacific Biosciences posts net loss for Q4 and year 2017
Pacific Biosciences of California said in its fourth quarter results announcement that it has had 19% of increase in product, service…
Pharmaceuticals, Biotechnology and Life Sciences
Author: Dino Mustafić
February 2, 2018
Gilead sciences welcomes new board member
Gilead Sciences has appointed new member to its board of directors, Jacqueline K. Barton who has previously served on Gilead’s Scientific…
February 2, 2018
Cardinal Health sells its China-based subsidiary to Shanghai Pharmaceuticals for $1.2 billion
Cardinal Health has disposed a business unit for $1.2 billion – its Cardinal Health China – to Shanghai Pharmaceuticals Holding.
February 2, 2018
Adler closes offering $250M of 2.50% Convertible Senior Notes Due 2025
A migraine treatment focused biopharmaceutical specialist, Alder BioPharmaceuticals, has closed on Thursday previously announced underwritten offering of $250 million aggregate…
February 1, 2018
Mylan launches Efavirenz in USA, first generic version of BMS’s HIV type 1 treatment Sustiva
Mylan is launching Efavirenz Tablets USP, 600 mg, in the USA, the first generic version of Bristol-Myers Squibb’s Sustiva, which…
February 1, 2018
Faron to kick off developing Clevegen for cancer, as it got patent for its antibodies from European Patent Office
Faron Pharmaceuticals has gotten a patent from European Patent office, for Clever-1 antibodies, the mechanism for the Clevegen, the treatment…
February 1, 2018
Novo Nordisk’s study shows reductions in blood sugar and weight compared with dulaglutide for type 2 diabetes, sales in diabetes, obesity increased
Novo Nordisk has published the results for semaglutide from a study aiming to test the treatment for type 2 diabetes.
February 1, 2018
STADA announces the new CEO, to step in in September
Stada has announced the new name to succeed the current CEO Claudio Albrecht in September this year.
February 1, 2018
Vertex takes next step in testing medicine to treat the underlying cause of cystic fibrosis
Vertex Pharmaceuticals will move its cystic fibrosis treatment VX-659 and VX-445 into Phase 3, the company said Wednesday, after the initial…
February 1, 2018
Nordic Nanovector names new leader for communication with investors and media
Nordic Nanovector ASA has appointed Malene Brondberg as Vice President, Investor Relations and Corporate Communications. Malene will lead the engagement and…